MEAGAN ADAMSICK, PHARMD*

Articles by MEAGAN ADAMSICK, PHARMD*

Entering the Phase of Phage: A Closer Look at Bacteriophage Therapy

ByMEAGAN ADAMSICK, PHARMD*

December 20th 2020

The Early Bird Gets to Stay Home: Early OPAT Follow-Up Reduces 30-Day Readmissions

ByMEAGAN ADAMSICK, PHARMD*,MONIQUE R. BIDELL, PHARMD, BCPS

February 11th 2020

Readmission rates for patients receiving OPAT are reported to be as high as 20%, mostly due to catheter-related problems, adverse drug reactions, or worsening of the primary infection.

Latest Updated Articles

Entering the Phase of Phage: A Closer Look at Bacteriophage Therapy
Published: December 20th 2020 | Updated:
The Early Bird Gets to Stay Home: Early OPAT Follow-Up Reduces 30-Day Readmissions
Published: February 11th 2020 | Updated:

MEAGAN ADAMSICK, PHARMD*

Articles by MEAGAN ADAMSICK, PHARMD*

Entering the Phase of Phage: A Closer Look at Bacteriophage Therapy

The Early Bird Gets to Stay Home: Early OPAT Follow-Up Reduces 30-Day Readmissions

Latest Updated Articles

Trending on Contagion Live

Maternal and Infant RSV Immunization Safe, Boosts Antibody Levels Regardless of Sequence

HIV Providers: Shortages and Uneven Distribution Across the US

ViiV Healthcare Announces 96-Week PASO DOBLE Results Showing Dovato as Effective as Biktarvy in Maintaining Viral Suppression